Janux Therapeutics (JANX) Net Margin (2021 - 2026)
Janux Therapeutics (JANX) recorded Net Margin of -214.01% in Q2 2026, up 438.58 percentage points from the prior quarter.
Powered by 
Analysis
Janux Therapeutics (JANX) Net Margin (2021 - 2026) Analysis & Trends
On a TTM basis, Janux Therapeutics' Net Margin came in at -427.47% as of Jun 30, 2026, up 23636.54 percentage points year-over-year; for FY2025, it came in at -1136.25%, down 484.63 percentage points from FY2024.
- Annual Net Margin has a four-year change of -237.93 percentage points (FY2021 to FY2025).
- Across earlier years, Net Margin came in at -651.62% in FY2024 (+69.56 pp), -721.18% in FY2023 (+11.04 pp), -732.22% in FY2022 (+166.10 pp) and -898.32% in FY2021.
- The Q2 2026 figure is the highest quarterly Net Margin since Q2 2024.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 6148.44 percentage points in Q3 2025, against a drop of 5931.98 percentage points in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -1.65% |
| 10 | Janux Therapeutics | 1.07 Bn | -2.81 Bn | - | -214.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -214.01% |
| Mar 31, 2026 | -652.59% |
| Sep 30, 2025 | -243.13% |
| Sep 30, 2024 | -6,391.57% |
| Jun 30, 2024 | -66.98% |
| Mar 31, 2024 | -1,178.91% |
| Dec 31, 2023 | -477.77% |
| Sep 30, 2023 | -459.59% |
| Jun 30, 2023 | -1,656.39% |
| Mar 31, 2023 | -852.49% |
| Dec 31, 2022 | -564.67% |
| Sep 30, 2022 | -920.90% |
| Jun 30, 2022 | -714.08% |
| Mar 31, 2022 | -843.93% |
| Dec 31, 2021 | -830.20% |
| Sep 30, 2021 | -928.90% |
| Jun 30, 2021 | -1,287.55% |
| Mar 31, 2021 | -601.05% |
API Access
Janux Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();